Skip to main content
. 2024 Dec 24;24:490. doi: 10.1186/s12883-024-03990-9

Table 3.

Meta-analysis results

Outcome measures Study (Patient) SMD/MD (95%CI) P-value of the intervention effect Heterogeneity Publication bias
Cognitive function MOCA 3(n = 175) 2.98,(2.08;3.88) P = 0.000 I2 = 0%, P = 0.87
Depressive symptoms HAMD 4(n = 186) -0.43,(-0.72;-0.13) P = 0.004 I2 = 43%%, P = 0.14
Intervention Frequency
≥ 5 Hz 2(n = 114) -0.19,(-0.73; 0.35) P = 0.50 I2 = 51%, P = 0.13
≤ 1 Hz 2(n = 72) -0.88,(-1.37; -0.39) P = 0.0005 I2 = 0%, P = 0.42
Stimulation Site P = 0.361
DLPFC 2(n = 60) -0.23,(-0.76;0.30) P = 0.39 I2 = 82%, P = 0.02
M1 2(n = 126) -0.52,(-0.88;-0.16) P = 0.004 I2 = 0%, P = 0.74
Walk ability FOG-Q 3(n = 90) -0.54,(-0.97;-0.11) P = 0.01 I2 = 0%, P = 0.01;
TUGT 5(n = 178) -0.72,(-1.43; 0.00) P = 0.048 I2 = 81%, P = 0.000 Egger’s test, P = 0.243
Stimulation Site
M1 3(n = 83) -0.54,(-1.60; 0.52) P = 0.32 I2 = 0%, P = 0.85
DLPFC 2(n = 64) 1.19,(0.77; 1.61) P<0.00001 I2 = 0%, P = 0.68
SMA 1(n = 30) -5.8,(-7.95;-3.65) P<0.00001 -
UPDRSIII 11(n = 489) -0.66,(-0.84; -0.47) P = 0.000 I2 = 35%, P = 0.083 Egger’s test, P = 0.976